electroCore, Inc.
NASDAQ:ECOR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.2
12.32
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ECOR stock under the Base Case scenario is 17.59 USD. Compared to the current market price of 12.32 USD, electroCore, Inc. is Undervalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
electroCore, Inc.
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ECOR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
electroCore, Inc.
Balance Sheet Decomposition
electroCore, Inc.
Current Assets | 18m |
Cash & Short-Term Investments | 14.2m |
Receivables | 538k |
Other Current Assets | 3.2m |
Non-Current Assets | 4.4m |
PP&E | 4m |
Other Non-Current Assets | 440k |
Current Liabilities | 7.3m |
Accounts Payable | 1.5m |
Accrued Liabilities | 5.4m |
Other Current Liabilities | 402k |
Non-Current Liabilities | 3.6m |
Other Non-Current Liabilities | 3.6m |
Earnings Waterfall
electroCore, Inc.
Revenue
|
21.3m
USD
|
Cost of Revenue
|
-3.5m
USD
|
Gross Profit
|
17.8m
USD
|
Operating Expenses
|
-32.3m
USD
|
Operating Income
|
-14.5m
USD
|
Other Expenses
|
305k
USD
|
Net Income
|
-14.2m
USD
|
Free Cash Flow Analysis
electroCore, Inc.
USD | |
Free Cash Flow | USD |
ElectroCore reported its seventh consecutive record revenue quarter with $6.1 million in Q2 2024, a 73% increase from last year, driven by the strong performance of prescription gammaCore devices and Truvaga wellness products. Gross margins rose to 86%, and the net loss was reduced by 46%, showing significant operating leverage. The company’s cash position was bolstered by raising $9 million in June 2024 .
What is Earnings Call?
ECOR Profitability Score
Profitability Due Diligence
electroCore, Inc.'s profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
electroCore, Inc.'s profitability score is 30/100. The higher the profitability score, the more profitable the company is.
ECOR Solvency Score
Solvency Due Diligence
electroCore, Inc.'s solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
electroCore, Inc.'s solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ECOR Price Targets Summary
electroCore, Inc.
According to Wall Street analysts, the average 1-year price target for ECOR is 23.56 USD with a low forecast of 15.15 USD and a high forecast of 31.5 USD.
Dividends
Current shareholder yield for ECOR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ECOR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 52 full-time employees. The company went IPO on 2018-06-22. nVNS is a platform for bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The firm is providing gammaCore device for the treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults. gammaCore permits patients to self-administer doses of nVNS on an as-needed basis for treatment of prevent multiple types of headache pain via the vagus nerve. The gammaCore therapy is also used to treat primary headache, including migraine, cluster headache (CH), hemicrania continua and paroxysmal hemicrania (PH) and coronavirus (COVID-19).
Contact
IPO
Employees
Officers
The intrinsic value of one ECOR stock under the Base Case scenario is 17.59 USD.
Compared to the current market price of 12.32 USD, electroCore, Inc. is Undervalued by 30%.